NCT00230295View on ClinicalTrials.gov

Indirect Magnetic Resonance Lymphangiography of the Head and Neck Region Using Conventional Gadolinium-based Contrast

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions

Head and Neck CancerHead and Neck Cancers

Interventions

PROCEDURE

IMR LAG

Trial Locations (1)

94305

Stanford University School of Medicine, Stanford

All Listed Sponsors

collaborator

McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

INDUSTRY

lead

Stanford University

OTHER

NCT00230295 - Indirect Magnetic Resonance Lymphangiography of the Head and Neck Region Using Conventional Gadolinium-based Contrast | Biotech Hunter | Biotech Hunter